Royal Bank of Canada Increases Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target to $15.00

Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) had its price objective boosted by Royal Bank of Canada from $14.00 to $15.00 in a research note published on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. Separately, Canaccord Genuity Group assumed coverage on shares of Mind Medicine (MindMed) in a research […]

Leave a Reply

Your email address will not be published.

Previous post Squarespace (NYSE:SQSP) Given New $42.00 Price Target at Citigroup
Next post Comparing Private Bancorp of America (OTCMKTS:PBAM) & First Republic Bank (OTCMKTS:FRCB)